Compare · BSX vs SDC
BSX vs SDC
Side-by-side comparison of Boston Scientific Corporation (BSX) and SmileDirectClub Inc. (SDC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and SDC operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX carries a market cap of $64.27B.
- BSX has hit the wire 12 times in the past 4 weeks while SDC has been quiet.
- BSX has more recent analyst coverage (25 ratings vs 23 for SDC).
- Company
- Boston Scientific Corporation
- SmileDirectClub Inc.
- Price
- -
- -
- Market cap
- $64.27B
- -
- 1M return
- +0.43%
- -
- 1Y return
- -56.40%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 23
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
SmileDirectClub Inc.
SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
Latest BSX
- Chairman, President & CEO Mahoney Michael F received a gift of 252,241 shares (SEC Form 4)
- SVP, Chief HR Officer O'Sullivan Miriam converted options into 3,871 shares and covered exercise/tax liability with 1,872 shares, increasing direct ownership by 11% to 19,565 units (SEC Form 4)
- Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
- SEC Form 10-Q filed by Boston Scientific Corporation
- SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
- Boston Scientific downgraded by TD Cowen with a new price target
- Penumbra, Inc. Reports Third Quarter 2026 Financial Results
- Boston Scientific downgraded by Oppenheimer
- Boston Scientific downgraded by Analyst with a new price target
- SEC Form 8-K filed by Boston Scientific Corporation
Latest SDC
- SEC Form 25-NSE filed by SmileDirectClub Inc.
- Stocks That Hit 52-Week Lows On Tuesday
- Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
- Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Nasdaq Down Over 200 Points; US Job Openings Rise In August
- SmileDirectClub shares are trading lower after the company reported it received notice that its securities will be delisted from the Nasdaq.
- Dow Falls Over 100 Points; McCormick Sales Miss Views
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket